Luvesilocin: This new psychedelic drug could change how we treat postpartum depression
In recent FDA Phase 2 trials, a single dose of the experimental psychedelic luvesilocin eliminated postpartum depression symptoms in 71%...
Read moreDetailsIn recent FDA Phase 2 trials, a single dose of the experimental psychedelic luvesilocin eliminated postpartum depression symptoms in 71%...
Read moreDetails